Milae Bioresources Co., Ltd. (KOSDAQ: 218150)

Milae Bioresources Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7,106	1,992	7,552	18,149	2,811	4,465
Short-Term Investments	16,862	23,262	19,840	9,562	10,136	9,206
Cash & Short-Term Investments	23,968	25,254	27,392	27,711	12,947	13,671
Cash Growth	-9.62%	-7.81%	-1.15%	114.03%	-5.29%	26.09%
Accounts Receivable	10,176	7,386	8,991	8,446	8,699	9,521
Other Receivables	301.52	440.12	251.31	63.25	51.72	92.55
Receivables	10,487	7,826	9,295	8,562	8,766	9,613
Inventory	5,317	4,335	5,116	5,103	3,358	2,687
Prepaid Expenses	11.5	7.33	8.47	7.63	136.22	198.08
Other Current Assets	177.66	512.98	159.93	139.92	105.11	470.72
Total Current Assets	39,962	37,935	41,972	41,524	25,313	26,639
Property, Plant & Equipment	11,060	11,191	11,387	11,436	11,263	11,086
Long-Term Investments	-	-	2.08	498.97	246.78	137.65
Goodwill	1,229	1,229	1,586	1,156	1,156	-
Other Intangible Assets	143.17	178.6	239.66	407.66	481.22	0.45
Long-Term Accounts Receivable	-0	-0	-0	0	0	0
Long-Term Deferred Tax Assets	530.22	483.05	397.91	157.26	435.43	394.29
Other Long-Term Assets	909.48	573.96	510.51	210.88	168.99	260.87
Total Assets	53,833	51,591	56,095	55,390	39,064	38,519
Accounts Payable	2,629	1,980	2,162	3,290	2,437	3,586
Accrued Expenses	270.32	209.53	223.79	185.73	190.81	101.68
Short-Term Debt	4,088	2,686	10,198	2,322	4,424	3,400
Current Portion of Long-Term Debt	541.5	550	550	-	14.16	-
Current Portion of Leases	239.18	194.91	246.56	192.57	122.39	162.35
Current Income Taxes Payable	47.13	-	123.22	-	63.45	310.28
Other Current Liabilities	1,527	1,506	1,437	1,442	972.1	1,025
Total Current Liabilities	9,343	7,126	14,941	7,432	8,224	8,586
Long-Term Debt	50	50	-	14,517	-	-
Long-Term Leases	335.87	237.74	311.38	338.98	151.85	216.19
Other Long-Term Liabilities	9.06	9.01	8.37	42.89	1.06	56
Total Liabilities	9,746	7,430	15,260	22,331	8,377	8,858
Common Stock	2,042	2,042	1,990	1,867	1,867	1,867
Additional Paid-In Capital	22,009	22,009	19,103	12,316	10,809	10,601
Retained Earnings	21,468	21,447	21,019	20,057	18,914	17,964
Treasury Stock	-979.15	-979.15	-979.15	-994.58	-1,041	-774.76
Comprensive Income & Other	-411.13	-365.24	-387.2	-359.74	-99.99	4.1
Total Common Equity	44,128	44,153	40,745	32,885	30,449	29,661
Minority Interest	-41.21	7.22	89.36	173.98	237.76	-
Shareholders' Equity	44,087	44,160	40,835	33,059	30,687	29,661
Total Liabilities & Equity	53,833	51,591	56,095	55,390	39,064	38,519
Total Debt	5,255	3,719	11,306	17,370	4,712	3,778
Net Cash (Debt)	18,713	21,535	16,086	10,341	8,235	9,893
Net Cash Growth	41.79%	33.88%	55.56%	25.57%	-16.75%	37.87%
Net Cash Per Share	920.45	1119.39	860.34	583.56	464.46	557.18
Filing Date Shares Outstanding	19.37	19.5	18.98	17.74	17.69	17.79
Total Common Shares Outstanding	19.37	19.5	18.98	17.74	17.69	17.79
Working Capital	30,619	30,809	27,031	34,092	17,089	18,054
Book Value Per Share	2278.26	2264.77	2147.25	1854.08	1720.97	1667.62
Tangible Book Value	42,756	42,745	38,920	31,322	28,813	29,661
Tangible Book Value Per Share	2207.40	2192.55	2051.06	1765.94	1628.46	1667.59
Land	6,107	6,107	6,107	6,107	6,107	5,969
Buildings	4,289	4,289	4,289	4,289	4,289	3,813
Machinery	3,994	3,975	3,760	3,461	3,235	2,902
Construction In Progress	458.72	459.56	234.2	139.81	178.56	178.56

Source: S&P Capital IQ. Standard template. Financial Sources.